BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences

2024-03-04

BOTHELL, Wash., March 4, 2024 /PRNewswire/ -- BioLife Solutions Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced that Roderick de Greef, Chief Executive Officer, and Troy Wichterman, Chief Financial Officer, will present and meet with current and prospective investors at the following March Investor Conferences. TD Cowen 44th Annual Healthcare Conference (Boston, MA): March 5-6th 1:1 Meeting on both days Fireside chat – Wednesday March 6th 9:15-9:45am ET Key Banc Virtual Conference: March 20th Fireside chat – 11:15 am-12:00 pm PT About BioLife Solutions BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit or follow BioLife on LinkedIn and X. Media & Investor Relations At the Company Troy Wichterman Chief Financial Officer (425) 402-1400 twichterman@biolifesolutions.com Company Codes: NASDAQ-SMALL:BLFS

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构